The first Aerie Pharmaceuticals trade was made in Q4 2014.
Since then Steven Cohen bought shares seven more times and sold shares on eight occasions. The investor completely sold their stake between Q2 2022 and Q3 2022.
Avg closing price
Price range
Sold -31.9 Thousand shares
Q3 2022
Avg closing price
$11.62
Price range
$6.37
-
$15.23
Sold 96.8% shares (-958 Thousand shares)
Q2 2022
Avg closing price
$7.05
Price range
$4.95
-
$9.16
New holding (+990 Thousand shares)
Q1 2022
Avg closing price
$7.71
Price range
$5.64
-
$9.80
Sold -184 Thousand shares
Q4 2020
Avg closing price
$12.08
Price range
$9.12
-
$14.49
Sold 78.4% shares (-667 Thousand shares)
Q3 2020
Avg closing price
$12.18
Price range
$10.46
-
$14.46
Increased shares by 110.2% (+446 Thousand shares)
Q2 2020
Avg closing price
$14.79
Price range
$12.00
-
$16.13
New holding (+405 Thousand shares)
Q1 2020
Avg closing price
$18.97
Price range
$11.84
-
$25.52
Sold -1.41 Million shares
Q4 2019
Avg closing price
$20.71
Price range
$17.72
-
$25.10
New holding (+1.41 Million shares)
Q3 2019
Avg closing price
$22.91
Price range
$18.41
-
$28.00
Sold -203 Thousand shares
Q4 2018
Avg closing price
$46.91
Price range
$33.00
-
$60.04
Increased shares by 11.5% (+20.9 Thousand shares)
Q3 2018